OBJECTIVES: Immunological abnormalities in idiopathic dilated cardiomyopathy (DCM) include an increase in soluble interleukin (IL)-2 receptor, disease specific cardiac autoantibodies, an HLA-DR4 association, and familial aggregation of disease; however, cytokine profiles have not been defined. Serum concentrations of IL-2, IL-4, IL-10, and IL-12 were measured in patients with DCM (WHO criteria), relatives with asymptomatic left ventricular enlargement (LVE), patients with ischaemic heart failure (IHD), and healthy controls. DESIGN: Serum from 20 individuals from each of the four groups was assayed for cytokine concentrations by a commercial enzyme linked immunosorbent assay. RESULTS: IL-2 concentrations were abnormally increased in DCM patients and relatives with LVE. Concentrations of IL-10 were increased in DCM patients. Concentrations of IL-4 and IL-12 were not increased in any of the groups. CONCLUSION: These abnormalities may reflect defective/inappropriate T cell function in patients with DCM and in their relatives with LVE.
OBJECTIVES: Immunological abnormalities in idiopathic dilated cardiomyopathy (DCM) include an increase in soluble interleukin (IL)-2 receptor, disease specific cardiac autoantibodies, an HLA-DR4 association, and familial aggregation of disease; however, cytokine profiles have not been defined. Serum concentrations of IL-2, IL-4, IL-10, and IL-12 were measured in patients with DCM (WHO criteria), relatives with asymptomatic left ventricular enlargement (LVE), patients with ischaemic heart failure (IHD), and healthy controls. DESIGN: Serum from 20 individuals from each of the four groups was assayed for cytokine concentrations by a commercial enzyme linked immunosorbent assay. RESULTS:IL-2 concentrations were abnormally increased in DCMpatients and relatives with LVE. Concentrations of IL-10 were increased in DCMpatients. Concentrations of IL-4 and IL-12 were not increased in any of the groups. CONCLUSION: These abnormalities may reflect defective/inappropriate T cell function in patients with DCM and in their relatives with LVE.
Authors: A L Caforio; G F Bottazzo; W J McKenna; P J Counihan; M Burke; J Poloniecki; M J Davies; J R Pepper Journal: Transplant Proc Date: 1990-08 Impact factor: 1.066
Authors: H T Aretz; M E Billingham; W D Edwards; S M Factor; J T Fallon; J J Fenoglio; E G Olsen; F J Schoen Journal: Am J Cardiovasc Pathol Date: 1987-01
Authors: A L Caforio; E Bonifacio; J T Stewart; D Neglia; O Parodi; G F Bottazzo; W J McKenna Journal: J Am Coll Cardiol Date: 1990-06 Impact factor: 24.094
Authors: P F Currie; J H Goldman; A L Caforio; A J Jacob; M K Baig; R P Brettle; A J Haven; N A Boon; W J McKenna Journal: Heart Date: 1998-06 Impact factor: 5.994
Authors: F Picard; M Brehm; M Fassbach; B Pelzer; S Scheuring; P Küry; B E Strauer; B Schwartzkopff Journal: Clin Res Cardiol Date: 2006-04-03 Impact factor: 6.138
Authors: Louise Emilsson; Bert Andersson; Peter Elfström; Peter H R Green; Jonas F Ludvigsson Journal: J Am Heart Assoc Date: 2012-06-22 Impact factor: 5.501